Known active central nervous system metastases, brain metastases, or carcinomatous meningitis
Known untreated central nervous system metastases and/or carcinomatous meningitis
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
Known active central nervous system metastases and/or carcinomatous meningitis
Known central nervous system (CNS) metastases and/or carcinomatous meningitis (includes past history or current metastasis)
Active central nervous system (CNS) metastases and/or carcinomatous meningitis
Has a known active central nervous system metastasis and/or carcinomatous meningitis.
Known active central nervous system metastases and/or carcinomatous meningitis.
Active central nervous system metastases and/or carcinomatous meningitis
Has known untreated central nervous system (CNS) metastases and/or carcinomatous meningitis
Has clinically active central nervous system (CNS) metastases and/or carcinomatous meningitis.
Known uncontrolled central nervous system (CNS) metastases and/or carcinomatous meningitis or known malignancy that progressed or required active treatment within the last  years
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
EXCLUSION - PARTICIPANT: Participants with known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Documented active or untreated central nervous system (CNS) metastases and/or carcinomatous meningitis;
Has known active (=growing) central nervous system (CNS) metastases and/or carcinomatous meningitis; radiation or resected brain metastasis are acceptable if clinically stable
Has radiographically detectable central nervous system metastases and/or carcinomatous meningitis as assessed by local site investigator at the time of diagnosis
Known untreated central nervous system metastases and/or carcinomatous meningitis.
Poorly controlled or symptomatic central nervous system (CNS) metastases or carcinomatous meningitis
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis and/or has known active central nervous system (CNS) leukemia involvement
Known central nervous system (CNS) metastases and/or carcinomatous meningitis
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
Subjects with untreated central nervous system (CNS) metastases or carcinomatous meningitis are excluded
Has known central nervous system (CNS) metastases and/or carcinomatous meningitis
Has radiographically detectable (even if asymptomatic and/or previously treated) central nervous system (CNS) metastases and/or carcinomatous meningitis as assessed by local site investigator and radiology review/CIV
Has radiographically detectable (even if asymptomatic and/or previously treated) central nervous system (CNS) metastases and/or carcinomatous meningitis as assessed by local site investigator and radiology review
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Has radiographically detectable (even if asymptomatic and/or previously treated) central nervous system (CNS) metastases and/or carcinomatous meningitis as assessed by principal investigator (PI) and radiology review
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Active central nervous system metastasis and/or carcinomatous meningitis causing symptoms
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
Has known central nervous system (CNS) metastases and/or carcinomatous meningitis
Patients with carcinomatous meningitis or active central nervous system (CNS) metastases
Known untreated central nervous system (CNS) metastases and/or carcinomatous meningitis
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Symptomatic Central nervous system (CNS) metastases and/or carcinomatous meningitis
Subject has known active central nervous system metastases and/or carcinomatous meningitis.
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Has known active (growing) central nervous system (CNS) metastases and/or carcinomatous meningitis; prior radiation or resection is acceptable if clinically stable for at least  weeks
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Known active central nervous system metastases and/or carcinomatous meningitis
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Has known history of, or any evidence of, central nervous system (CNS) metastases and/or carcinomatous meningitis.
Has known active central nervous system metastases and/or carcinomatous meningitis.
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
Known active central nervous system metastases and/or carcinomatous meningitis.
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
Active central nervous system metastases and/or carcinomatous meningitis
Carcinomatous meningitis and/or symptomatic central nervous system (CNS) metastases.
Active central nervous system (CNS) metastases and/or carcinomatous meningitis
Known active central nervous system metastases and/or carcinomatous meningitis.
Has radiographically detectable central nervous system (CNS) metastases and/or carcinomatous meningitis
Known central nervous system metastases and/or carcinomatous meningitis
Has untreated central nervous system (CNS) metastases and/or carcinomatous meningitis
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis.
Active central nervous system metastases and/or carcinomatous meningitis
Known central nervous system (CNS) metastases and/or carcinomatous meningitis
Clinically apparent central nervous system metastases or carcinomatous meningitis
Known central nervous system (CNS) metastases and/or carcinomatous meningitis
Known central nervous system metastases and/or carcinomatous meningitis.
Known active central nervous system metastases and/or carcinomatous meningitis.
Known central nervous system metastases and/or carcinomatous meningitis
Known central nervous system metastases and/or carcinomatous meningitis
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Known central nervous system (CNS) metastases and/or carcinomatous meningitis
Active central nervous system metastases and/or carcinomatous meningitis
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Known or suspected brain or central nervous system (CNS) metastases, or carcinomatous meningitis
Has known active central nervous system disease and/or carcinomatous meningitis
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Active central nervous system (CNS) metastases and/or carcinomatous meningitis
Has clinically active central nervous system (CNS) metastases and/or carcinomatous meningitis
Patients with either clinically apparent central nervous system metastases or carcinomatous meningitis are ineligible
The patient has either clinically apparent central nervous system metastases or carcinomatous meningitis
Has known active central nervous system metastases and/or carcinomatous meningitis.
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Known central nervous system (CNS) metastases and/or carcinomatous meningitis.
Known active central nervous system metastases and/or carcinomatous meningitis.
Active Central Nervous System (CNS) metastases or carcinomatous meningitis
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
Has known active (= growing) central nervous system (CNS) metastases and/or carcinomatous meningitis; radiation or resected brain metastasis are acceptable if clinically stable
Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis